TuHURA Biosciences, Inc. HURA Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Returns | ||||
| Return on equity | -169.2%— | —— | —— | |
| Return on assets | -127%+51.2pp | -178.2%+232pp | -410.6%— | |
| Efficiency | ||||
| Asset turnover | 0×— | 0×— | 0×— | |
| Liquidity | ||||
| Current ratio | 0.8×-2.9× | 3.7×+2.5× | 1.2×-1.7× | |
| Quick ratio | 0.8×-2.9× | 3.7×+2.5× | 1.2×-1.7× | |
| Cash ratio | 0.6×-1.8× | 2.4×+1.4× | 1×-0.5× | |
| Leverage | ||||
| Debt-to-equity | 0×0.0× | 0×— | —— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×— | |
| Per Share | ||||
| Book value per share | $0.44-44.1% | $0.78+696% | -$0.13— | |
| Valuation | ||||
| Market capitalization | $155.39M+45.8% | $172.94M— | —— | |
| Enterprise value | $149.54M+52.3% | $160.49M— | —— | |
| Price / book | 6.7×+1.2× | 11.9×— | —— | |
| Free cash flow yield | -17.6%-1.8pp | -8.5%— | —— | |
| Earnings yield | -19.9%+6.1pp | -12.5%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do TuHURA Biosciences, Inc.'s ratios come from?
- Every ratio is computed from TuHURA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.